Publication | Open Access
MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells
58
Citations
34
References
2017
Year
MELK inhibition by OTSSP167 may thus present a strategy to treat patients with aggressive, progressive, and recurrent ovarian cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1